Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Jerome Guitton"'
Autor:
Marie Piecyk, Mouna Triki, Pierre‐Alexandre Laval, Cedric Duret, Joelle Fauvre, Laura Cussonneau, Christelle Machon, Jerôme Guitton, Nicolas Rama, Benjamin Gibert, Gabriel Ichim, Frederic Catez, Fleur Bourdelais, Sebastien Durand, Jean‐Jacques Diaz, Isabelle Coste, Toufic Renno, Serge N. Manié, Nicolas Aznar, Stephane Ansieau, Carole Ferraro‐Peyret, Cedric Chaveroux
Publikováno v:
Molecular Oncology, Vol 18, Iss 9, Pp 2111-2135 (2024)
Nutrient availability is a key determinant of tumor cell behavior. While nutrient‐rich conditions favor proliferation and tumor growth, scarcity, and particularly glutamine starvation, promotes cell dedifferentiation and chemoresistance. Here, link
Externí odkaz:
https://doaj.org/article/89467b01b1f341de9d7f3e3b189e80c0
Autor:
Michael Philippe, Jerome Guitton, Bertrand Favier, Clemence Santana, Emmanuelle Nicolas-Virelizier, Yann Guillermin, Anne-Sophie Michallet, Mauricette Michallet, Amine Belhabri
Publikováno v:
Blood. 140:6179-6180
Autor:
Helena Dragic, Audrey Barthelaix, Cédric Duret, Simon Le Goupil, Hadrien Laprade, Sophie Martin, Sabine Brugière, Yohann Couté, Christelle Machon, Jerome Guitton, Justine Rudewicz, Paul Hofman, Serge Lebecque, Cedric Chaveroux, Carole Ferraro-Peyret, Toufic Renno, Serge N Manié
Publikováno v:
Life Science Alliance
Life Science Alliance, 2022, 5 (7), pp.e202101334. ⟨10.26508/lsa.202101334⟩
Life Science Alliance, 2022, 5 (7), pp.e202101334. ⟨10.26508/lsa.202101334⟩
The glucose-requiring hexosamine biosynthetic pathway (HBP), which produces UDP-N-acetylglucosamine for glycosylation reactions, promotes lung adenocarcinoma (LUAD) progression. However, lung tumor cells often reside in low-nutrient microenvironments
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f9de2ded202d9df16d9a462ae49b57c
https://hal.science/hal-03660129/document
https://hal.science/hal-03660129/document
Autor:
Alaa Al Assi, Solène Posty, Frédéric Lamarche, Amel Chebel, Jérôme Guitton, Cécile Cottet-Rousselle, Renaud Prudent, Laurence Lafanechère, Stéphane Giraud, Patrick Dallemagne, Peggy Suzanne, Aurélie Verney, Laurent Genestier, Marie Castets, Eric Fontaine, Marc Billaud, Martine Cordier-Bussat
Publikováno v:
Cell Death and Disease, Vol 15, Iss 5, Pp 1-14 (2024)
Abstract Cancer cells are highly dependent on bioenergetic processes to support their growth and survival. Disruption of metabolic pathways, particularly by targeting the mitochondrial electron transport chain complexes (ETC-I to V) has become an att
Externí odkaz:
https://doaj.org/article/3280099ad7854690b1351796393f9c52
Autor:
David Barthelemy, Arnaud Vigneron, Xavier Rousset, Jerome Guitton, Emmanuel Grolleau, Margaux Raffin, Julie Balandier, Gaelle Lescuyer, Florence Geiguer, Sebastien Couraud, Jean Vaillet, Nazim Benzerdjeb, Lea Payen-Gay
Publikováno v:
Cancer Research. 83:4866-4866
Introduction: NSCLC accounts for about 80-85% of all lung cancers. Approximately 10-50% of patients with NSCLC harbor EGFR activating mutations, such as in-frame deletions in exon 19 (Ex19del). Currently, for patients with advanced NSCLC, testing for
Autor:
Jerome Alexandre, Stephane Oudard, Luca Campedel, Lisa Golmard, Sylvain Ladoire, Ahmed Khalil, Denis Maillet, Christophe Tournigand, Françoise Goirand, Jerome Guitton, Charles Dariane, Florence Joly, Evanguelos Xylinas, Jean Louis Golmard, Hendy Abdoul, Nihel Khoudour, Alicja Puskiel, Edith Carton, Olivier Huillard, Benoit Blanchet
Publikováno v:
Journal of Clinical Oncology. 41:159-159
159 Background: Abiraterone acetate (ABI) improves survival in mCRPC. In a previous observational study, worse PSA response and shorter progression-free survival (PFS) were associated with mean ABI plasma through concentration (ABI Cmin) < 8.5 ng/mL
Autor:
Olivia Febvey-Combes, Jérôme Guitton, Perrine Marec-Berard, Cécile Faure-Conter, Ellen Blanc, Sylvie Chabaud, Agnès Conjard-Duplany, Matthias Schell, Laurence Derain Dubourg
Publikováno v:
BMC Pediatrics, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background Ifosfamide is a major anti-cancer drug in children with well-known renal toxicity. Understanding the mechanisms underlying this toxicity could help identify children at increased risk of toxicity. Methods The IFOS01 study included
Externí odkaz:
https://doaj.org/article/ce3b1eaa51544e12ab9223cb32a886ff
Autor:
Jerome, Guitton, Mohamed, Soumah
Publikováno v:
In Software Impacts September 2023 17
Autor:
Laurence Gilles-Afchain, Gabriel Salguero-Hernandez, Philippe-Henri Secrétan, Vicky Valverde, Jonathan Batista, Joël Schlatter, Julia Rousseau, Jerome Guitton, Fabrice Vidal, Salvatore Cisternino, Camille Cotteret
Publikováno v:
European journal of hospital pharmacy : science and practice. 29(5)
Risk management for workers involved in the handling and preparation of cytotoxic drugs is challenging. This study aims to investigate drug contamination of the exterior surfaces of cytotoxic drug vials. Two batches of commercially available cytotoxi
Autor:
Jérémy Béguin, Eve Laloy, Sandrine Cochin, Murielle Gantzer, Isabelle Farine, Christelle Pichon, Baptiste Moreau, Johann Foloppe, Jean-Marc Balloul, Christelle Machon, Jérôme Guitton, Dominique Tierny, Bernard Klonjkowski, Eric Quéméneur, Christelle Maurey, Philippe Erbs
Publikováno v:
Molecular Therapy: Oncolytics, Vol 30, Iss , Pp 103-116 (2023)
TG6002 is an oncolytic vaccinia virus expressing FCU1 protein, which converts 5-fluorocytosine into 5-fluorouracil. The study objectives were to assess tolerance, viral replication, 5-fluorouracil synthesis, and tumor microenvironment modifications t
Externí odkaz:
https://doaj.org/article/158089590f2b4c318c0aec5c6f69e200